Global Rosacea Pipeline Insight Reprt 2018: Pipeline (Under Development) Therapeutics Scenario and Growth Prospects

Dublin, Feb. 22, 2018 -- The "Rosacea - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Rosacea - Pipeline Insight, 2018' report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rosacea development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Rosacea

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Rosacea
The report assesses the active Rosacea pipeline products by developmental stage, product type, molecule type, and administration route.

Scope of the report:

• The report provides a snapshot of the pipeline development for the Rosacea
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Rosacea
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Rosacea
• The report also covers the dormant and discontinued pipeline projects related to the Rosacea

Reasons to Purchase:

• Establish comprehensive understanding of the pipeline activity across this Rosacea to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Rosacea therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Key Topics Covered:

1. Report Introduction

2. Rosacea Overview

3. Pipeline Therapeutics

• An Overview of Pipeline Products for Rosacea

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name : Company Name

• Product Description
• Research and Development
• Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name

• Product Description
• Research and Development
• Product Development Activities

7. Therapeutic Assessment

• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name : Company Name

• Product Description
• Research and Development
• Product Development Activities

Appendix
Report Methodology
Consulting Services
Disclaimer

List of Tables:
Table 1: Total Products for Rosacea
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List of Figures:
Figure 1: Total Products for Rosacea
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

Companies Mentioned

• Amorepacific Corp
• BioPharmX Inc
• Cutanea Life Sciences Inc
• ELORAC Inc
• Foamix Pharmaceuticals Ltd
• Hovione FarmaCiencia SA
• Promius Pharma LLC
• Sol-Gel Technologies Ltd
• TWi Biotechnology

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/x8w7v3/global_rosacea?w=12

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Immune Disorders Drugs, Dermatological Drugs